MetaPhore Pharmaceuticals
2 clinical trials · Sponsor
◉ Watch MetaPhore Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain (NCT00101621) | MetaPhore Pharmaceuticals | 2004-08-01 |
| Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 (NCT00033956) | MetaPhore Pharmaceuticals | 2001-12-01 |
Track MetaPhore Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.